Literature DB >> 10991856

Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test.

R Ramani1, V Chaturvedi.   

Abstract

Candida species other than Candida albicans frequently cause nosocomial infections in immunocompromised patients. Some of these pathogens have either variable susceptibility patterns or intrinsic resistance against common azoles. The availability of a rapid and reproducible susceptibility-testing method is likely to help in the selection of an appropriate regimen for therapy. A flow cytometry (FC) method was used in the present study for susceptibility testing of Candida glabrata, Candida guilliermondii, Candida krusei, Candida lusitaniae, Candida parapsilosis, Candida tropicalis, and Cryptococcus neoformans based on accumulation of the DNA binding dye propidium iodide (PI). The results were compared with MIC results obtained for amphotericin B and fluconazole using the NCCLS broth microdilution method (M27-A). For FC, the yeast inoculum was prepared spectrophotometrically, the drugs were diluted in either RPMI 1640 or yeast nitrogen base containing 1% dextrose, and yeast samples and drug dilutions were incubated with amphotericin B and fluconazole, respectively, for 4 to 6 h. Sodium deoxycholate and PI were added at the end of incubation, and fluorescence was measured with a FACScan flow cytometer (Becton Dickinson). The lowest drug concentration that showed a 50% increase in mean channel fluorescence compared to that of the growth control was designated the MIC. All tests were repeated once. The MICs obtained by FC for all yeast isolates except C. lusitaniae were in very good agreement (within 1 dilution) of the results of the NCCLS broth microdilution method. Paired t test values were not statistically significant (P = 0.377 for amphotericin B; P = 0.383 for fluconazole). Exceptionally, C. lusitaniae isolates showed higher MICs (2 dilutions or more) than in the corresponding NCCLS broth microdilution method for amphotericin B. Overall, FC antifungal susceptibility testing provided rapid, reproducible results that were statistically comparable to those obtained with the NCCLS method.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991856      PMCID: PMC90147          DOI: 10.1128/AAC.44.10.2752-2758.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 2.  Antifungal susceptibility testing: technical advances and potential clinical applications.

Authors:  M A Pfaller; J H Rex; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

3.  Rapid susceptibility testing of fungi by flow cytometry using vital staining.

Authors:  C Wenisch; K F Linnau; B Parschalk; K Zedtwitz-Liebenstein; A Georgopoulos
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Detection of amphotericin B-resistant Candida isolates in a broth-based system.

Authors:  J H Rex; C R Cooper; W G Merz; J N Galgiani; E J Anaissie
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

Review 5.  Antibiotic susceptibility testing by flow cytometry.

Authors:  R S Pore
Journal:  J Antimicrob Chemother       Date:  1994-11       Impact factor: 5.790

6.  Rapid determination of antifungal activity by flow cytometry.

Authors:  L Green; B Petersen; L Steimel; P Haeber; W Current
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  The trailing end point phenotype in antifungal susceptibility testing is pH dependent.

Authors:  K A Marr; T R Rustad; J H Rex; T C White
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

8.  Rapid susceptibility testing of Candida albicans by flow cytometry.

Authors:  S M Kirk; S M Callister; L C Lim; R F Schell
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

9.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

10.  Amphotericin B susceptibility of Candida species assessed by rapid flow cytometric membrane potential assay.

Authors:  J V Ordóñez; N M Wehman
Journal:  Cytometry       Date:  1995-06-15
View more
  23 in total

1.  Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome.

Authors:  C Wenisch; C B Moore; R Krause; E Presterl; P Pichna; D W Denning
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 2.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole.

Authors:  Rama Ramani; Madhurama Gangwar; Vishnu Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

4.  Collaborative study of the NCCLS and flow cytometry methods for antifungal susceptibility testing of Candida albicans.

Authors:  Vishnu Chaturvedi; Rama Ramani; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

5.  Collaborative study of antibiotic medium 3 and flow cytometry for identification of amphotericin B-resistant Candida isolates.

Authors:  Vishnu Chaturvedi; Rama Ramani; John H Rex
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  Flow cytometry susceptibility testing for the antifungal caspofungin.

Authors:  M Mitchell; M Hudspeth; A Wright
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?

Authors:  Susanne Perkhofer; Cornelia Mrazek; Lukas Hartl; Cornelia Lass-Flörl
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

8.  Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.

Authors:  Joanne Peter; Derek Armstrong; Caron A Lyman; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

9.  Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole.

Authors:  Carolina Mateus; Sidney A Crow; Donald G Ahearn
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Conidial viability assay for rapid susceptibility testing of Aspergillus species.

Authors:  S Arunmozhi Balajee; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.